Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
As-needed vs Regular Budesonide/Formoterol in Mild-Moderate Asthma
NCT00849095Phase 3Completed
- Sponsor
- University of Ferrara
- Start
- Apr 2009
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide + formoterol in asthma (2 arms), sponsored by University of Ferrara. Primary endpoint: Relative risk for treatment failure at 52 weeks. Started Apr 2009; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00849095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849095.